• 1
    Tovey FI. Peptic ulcer in India and Bangladesh. Gut 1979; 20: 32942.
  • 2
    Tovey FI. Duodenal ulcer in China. J. Gastroenterol. Hepatol. 1992; 4: 42731.
  • 3
    Wong BCY, Ching CK, Lam SK et al. Differential north to south gastric cancer: Duodenal ulcer gradient in China. J. Gastroenterol. Hepatol. 1998; 13: 10507.
  • 4
    Tovey FI, Tunstall M. Duodenal ulcer in black populations in Africa south of the Sahara. Gut 1975; 16: 56476.
  • 5
    Holcombe C. The African enigma. Gut 1992; 33: 42931.
  • 6
    Pershu R. Peptic ulcer in Fiji. Fiji Med. J. 1975; 3: 14853.
  • 7
    Beg F, Oldmeadow M, Morris A, Miller M, Nicholson G. Campylobacter pylori infection in patients undergoing endoscopy in Fiji. NZ Med. J. 1988; 101: 1406.
  • 8
    Oshowo AO. The direction of relationship between Helicobacter pylori and duodenal ulceration. MSc thesis, University of London, 1999.
  • 9
    Jones DM, Eldridge J, Fox AJ, Sethi AJ, Whorwell PJ. Antibody to the gastric campylobacter-like organisms (Campylobacter pylori): Clinical correlation and distribution in the normal population. J. Med. Microbiol. 1986; 22: 5762.
  • 10
    Maher W, Jyotheeswaran S, Potter G et al. An epidemiological study of peptic ulcer disease patients in Greater Rochester, New York. Gastroenterology 1997; 112: A206.
  • 11
    Jyotheeswaran S, Shah AH, Jin HO, Potter GD, Ona FV, Chey WY. Prevalence of Helicobacter pylori in peptic ulcer patients in Greater Rochester NY. Is empirical triple therapy justified? Am. J. Gastroenterol. 1998; 93: 5748.
    Direct Link:
  • 12
    Greenberg PD, Albert CM, Ridker PM et al. Helicobacter pylori as a risk factor for peptic ulcer in patients taking low dose aspirin. Gastroenterology 1997; 112: A133.
  • 13
    Gislason GT, Emu B, Okolo III P, Pasricha PJ, Kalloo AM. Where have all the Helicobacter gone? Etiologic factors in patients with duodenal ulcers presenting to a University Hospital. Gastrointest. Endosc. 1997; 45: A263.
  • 14
    Fenger HJ, Gudmand-Hoyer E. Peptic ulcer in the Greenland Inuit: Evidence for a low prevalence of duodenal ulcer. Int. J. Circumpolar Health 1997; 56: 649.
  • 15
    Mirghani YAA, Ahmed SAA, Karnel M, Ismail MD. Detection of Helicobacter pylori in endoscopy patients in Sudan. Trop. Doctor 1994; 24: 1613.
  • 16
    Kontou M, Katelaris PM. The prevalence of Helicobacter pylori and the spectrums of gastroduodenal ulcers in a cohort of Australian dyspeptic patients. Gut 1997; 41 (Suppl. 1): A37.
  • 17
    Uyub AM, Raj SM, Visvanathan R et al. Helicobacter pylori infection in Peninsular Malaysia: Evidence for an unusually low prevalence. Scand. J. Gastroenterol. 1994; 29: 20913.
  • 18
    Petersen WL, Ciociola AA, Sykes DL, McSorley DJ, Webb DD. Ranitidine Bi citrate plus clarithromycin is effective for healing duodenal ulcer, eradicating Helicobacter pylori and reducing ulcer recurrence. Aliment. Pharmacol. Ther. 1996; 10: 2516.
  • 19
    Lanza F, Ciociola AA, Sykes DL, Heath A, McSorley DJ, Webb DD. Ranitidine Bi citrate plus clarithromycin is effective in eradicating Helicobacter pylori; healing duodenal ulcer and preventing ulcer relapse. Gastroenterology 1996; 110: A172.
  • 20
    Bruno JM, Jones HP, Kubik CM, Gmettinger JK. The low prevalence of Helicobacter pylori in a military treatment facility. Gastroenterology 1997; 112: A79.
  • 21
    Sprung DJ, Apter MN. What is the role of Helicobacter pylori in peptic ulcer and gastric cancer outside the big cities? J. Clin. Gastroenterol. 1998; 26: 603.
  • 22
    Sprung DJ, Gano B. The natural history of duodenal ulcer disease and how it relates to Helicobacter pylori. Am. J. Gastroenterol. 1997; 92: 1655 (Abstract).
  • 23
    Dres Pest P, Zarate J, Varsky C, Man F, Schraier M. Helicobacter pylori in recently diagnosed versus chronic duodenal ulcer. Acta Gastroent. Latinoamer 1996; 26: 2736.
  • 24
    Parsonnet J. Helicobacter pylori: The size of the problem. Gut 1998; 43 (Suppl. 1): S69.
  • 25
    Kurata JH, Nogawa AN. Meta-analysis of risk factors for peptic ulcer, NSAIDs, Helicobacter pylori and smoking. J. Clin. Gastroenterol. 1997; 24: 217.
  • 26
    Racz I, Szabo A, Pecsi GY, Cpöndes M, Erenyi A, Goda M. Gastric metaplasia, acid secretion and duodenal Helicobacter pylori colonisation in duodenal ulcer patients. Gut 1998; 43 (Suppl. 2): A61.
  • 27
    Kim N, Lim SH, Lee KH, Choi SE. Long-term effect of Helicobacter pylori eradication on gastric metaplasia in patients with duodenal ulcer. J. Clin. Gastroenterol. 1998; 27: 24657.
  • 28
    Pospai D, Vissuzaine C, Marrouche M, Forestier S, Joubert-Collin M, Mignom M. Helicobacter pylori colonisation of gastric metaplasia in proximal duodenum is not an obligatory condition for a duodenal ulcer development and a preferential one. Gut 1997; 41 (Suppl. 3): A54.
  • 29
    Pospai D, Vissuzaine C, Vallot M, Mignom H. Is Helicobacter pylori colonisation of gastric metaplasia in proximal duodenum determining either duodenal ulcer development or duodenal ulcer relapse? Gut 1997; 41 (Suppl. 3): A108.
  • 30
    Graham DY, Hirschowitz B, Ciociola AA et al. Ranitidine bismuth citrate and amoxicillin for the treatment of duodenal ulcer disease. Am. J. Gastroenterol. 1995: 90: 1634 (Abstract).
  • 31
    Laine L, Hopkins RJ, Girardi LS. Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been exaggerated? A meta-analysis of rigorously designed trials. Am. J. Gastroenterol. 1998; 93: 140915.
  • 32
    Patrick WJA, Denham D, Forrest APM. Mucous change in human duodenum: A light and electron microscopic study and correlation with disease and gastric acid secretion. Gut 1974; 15: 76776.
  • 33
    Wyatt JI, Rathbone BJ, Dixon MF, Heatley RV. Campylobacter pyloridis and acid induced gastric metaplasia in the pathogenesis of duodenitis. J. Clin. Pathol. 1987; 40: 8418.
  • 34
    Harris AW, Gummett PA, Walker MM, Misiewicz JJ, Baron JH. Relation between gastric acid output, Helicobacter pylori and gastric metaplasia in the duodenal bulb. Gut 1996; 39: 51320.
  • 35
    McColl KEL. Helicobacter pylori, gastric acid and duodenal gastric metaplasia. Gut 1996; 39: 61516.
  • 36
    Biad A, Hamladji RM, Bouhadef A. Gastric metaplasia in normal man and patients with duodenal ulcer disease. Gut 1994; 35 (Suppl. 4): A131.
  • 37
    Tucci A, Susi D, Bovani I, Stranghellini V, Corinaldesi R, Barbara L. Effect of chronic acid inhibition on duodenal gastric metaplasia. Gastroenterology 1990; 98: A141.
  • 38
    Jayaraj AP, Tovey FI, Clark CG. Possible dietary protective factors in relation to the distribution of duodenal ulcer in India and Bangladesh. Gut 1980; 21: 106876.
  • 39
    Tovey FI, Jayaraj AP, Lewin MR, Clark CG. Diet: Its role in the genesis of peptic ulceration. Dig. Dis. 1989; 7: 30923.
  • 40
    Tovey FI. Diet and duodenal ulcer. J. Gastroenterol. Hepatol. 1994; 9: 17785.
  • 41
    Tovey FI, Hobsley M. Clarification of the link between polyunsaturated fatty acids and Helicobacter pylori- associated duodenal ulcer disease: A dietary intervention study. Br. J. Nutrition 1998; 80: 11517.
  • 42
    Tovey FI. Helicobacter pylori infection and upper gastrointestinal pathology in a British immigrant Indian community. Eur. J. Gastroenterol. Hepatol. 1997; 9: 647.
  • 43
    Tarnawski A, Hollander D, Gergely H. Protection of the gastric mucosa by linoleic acid: A nutrient-essential fatty acid. Clin. Invest. Med. 1987; 3: 1325.
  • 44
    Hollander D, Tarnawski A. Dietary essential fatty acids and the decline in peptic ulcer disease. Gut 1986; 27: 23942.
  • 45
    Grant HW, Palmer KR, Riermesma RR, Oliver MF. Duodenal ulcer is associated with low dietary linoleic acid intake. Gut 1990; 31: 9978.